| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $795.9M | +113.2% |
| SG&A Expense | $89.2M | +42.2% |
| Operating Income | -$885.1M | -103.0% |
| Pre-tax Income | -$845.7M | -106.5% |
| Income Tax | $735K | +153.1% |
| Net Income | -$846.4M | -107.4% |
| EPS (Basic) | -$9.28 | -62.0% |
| EPS (Diluted) | -$9.28 | -62.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $99.1M | -60.1% |
| Short-term Investments | $386.9M | +190.0% |
| Current Assets | $538.5M | +21.7% |
| Total Assets | $615.1M | +19.9% |
| Current Liabilities | $154.2M | +178.3% |
| Total Liabilities | $191.7M | +124.9% |
| Stockholders' Equity | $423.4M | -1.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$582.5M | -75.6% |
| Capital Expenditures | $4.0M | +32.8% |
| Investing Cash Flow | -$245.0M | -288.7% |
| Financing Cash Flow | $677.8M | +219.8% |
| Free Cash Flow | -$586.5M | -75.2% |